Prestige Consumer Healthc...

NYSE: PBH · Real-Time Price · USD
81.37
0.14 (0.17%)
At close: May 01, 2025, 12:10 PM
0.17%
Bid 81.36
Market Cap 4.03B
Revenue (ttm) 1.12B
Net Income (ttm) 213.94M
EPS (ttm) 4.26
PE Ratio (ttm) 19.1
Forward PE 16.95
Analyst Buy
Ask 81.69
Volume 148,927
Avg. Volume (20D) 373,160
Open 80.78
Previous Close 81.23
Day's Range 79.95 - 82.08
52-Week Range 62.35 - 90.04
Beta 0.47

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, ...

Sector Healthcare
IPO Date Feb 10, 2005
Employees 570
Stock Exchange NYSE
Ticker Symbol PBH
Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for PBH stock is "Buy." The 12-month stock price forecast is $98.5, which is an increase of 21.05% from the latest price.

Stock Forecasts

Next Earnings Release

Prestige Consumer Healthcare Inc. is scheduled to release its earnings on May 8, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+14.78%
Prestige Consumer Healthcare shares are trading hi... Unlock content with Pro Subscription